ArticleJournal for immunotherapy of cancer2021

Targeting PARP-1 with metronomic therapy modulates MDSC suppressive function and enhances anti-PD-1 immunotherapy in colon cancer.

Mohamed A Ghonim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.